Thromboprophylaxis for women undergoing caesarean section.

Hdl Handle:
http://hdl.handle.net/10147/220494
Title:
Thromboprophylaxis for women undergoing caesarean section.
Authors:
Kennedy, C; O'Dwyer, V; O'Kelly, S; Farah, N; Kennelly, M; Turner, M J
Affiliation:
UCD Centre for Human Reproduction, Coombe Women and Infant's University Hospital, Cork St, Dublin 8.
Citation:
Thromboprophylaxis for women undergoing caesarean section. 2012, 105 (2):56-7 Ir Med J
Journal:
Irish medical journal
Issue Date:
Feb-2012
URI:
http://hdl.handle.net/10147/220494
PubMed ID:
22455243
Abstract:
Thromboprophylaxis for women undergoing caesarean section (CS) was introduced in the hospital in 1995. This study audited the use of tinzaparin prophylaxis in a nested cohort of women who screened negative for diabetes mellitus at 28 weeks gestation. All the women had their weight measured and BMI calculated at the first antenatal visit. Of the 284 women, 68 (24%) had a CS and all received tinzaparin. Of the 68, however, 94% received a dose lower than recommended. Compliance with prophylaxis was complete but compliance with the recommended dosage was suboptimal, which may result in venous thromboembolism after CS despite thromboprophylaxis.
Item Type:
Article
Language:
en
Description:
Thromboprophylaxis for women undergoing caesarean section (CS) was introduced in the hospital in 1995. This study audited the use of tinzaparin prophylaxis in a nested cohort of women who screened negative for diabetes mellitus at 28 weeks gestation. All the women had their weight measured and BMI calculated at the first antenatal visit. Of the 284 women, 68 (24%) had a CS and all received tinzaparin. Of the 68, however, 94% received a dose lower than recommended. Compliance with prophylaxis was complete but compliance with the recommended dosage was suboptimal, which may result in venous thromboembolism after CS despite thromboprophylaxis.
MeSH:
Cesarean Section; Female; Fibrinolytic Agents; Guideline Adherence; Heparin, Low-Molecular-Weight; Humans; Prospective Studies; Venous Thrombosis
ISSN:
0332-3102

Full metadata record

DC FieldValue Language
dc.contributor.authorKennedy, Cen_GB
dc.contributor.authorO'Dwyer, Ven_GB
dc.contributor.authorO'Kelly, Sen_GB
dc.contributor.authorFarah, Nen_GB
dc.contributor.authorKennelly, Men_GB
dc.contributor.authorTurner, M Jen_GB
dc.date.accessioned2012-04-25T09:20:04Z-
dc.date.available2012-04-25T09:20:04Z-
dc.date.issued2012-02-
dc.identifier.citationThromboprophylaxis for women undergoing caesarean section. 2012, 105 (2):56-7 Ir Med Jen_GB
dc.identifier.issn0332-3102-
dc.identifier.pmid22455243-
dc.identifier.urihttp://hdl.handle.net/10147/220494-
dc.descriptionThromboprophylaxis for women undergoing caesarean section (CS) was introduced in the hospital in 1995. This study audited the use of tinzaparin prophylaxis in a nested cohort of women who screened negative for diabetes mellitus at 28 weeks gestation. All the women had their weight measured and BMI calculated at the first antenatal visit. Of the 284 women, 68 (24%) had a CS and all received tinzaparin. Of the 68, however, 94% received a dose lower than recommended. Compliance with prophylaxis was complete but compliance with the recommended dosage was suboptimal, which may result in venous thromboembolism after CS despite thromboprophylaxis.en_GB
dc.description.abstractThromboprophylaxis for women undergoing caesarean section (CS) was introduced in the hospital in 1995. This study audited the use of tinzaparin prophylaxis in a nested cohort of women who screened negative for diabetes mellitus at 28 weeks gestation. All the women had their weight measured and BMI calculated at the first antenatal visit. Of the 284 women, 68 (24%) had a CS and all received tinzaparin. Of the 68, however, 94% received a dose lower than recommended. Compliance with prophylaxis was complete but compliance with the recommended dosage was suboptimal, which may result in venous thromboembolism after CS despite thromboprophylaxis.-
dc.language.isoenen
dc.rightsArchived with thanks to Irish medical journalen_GB
dc.subject.meshCesarean Section-
dc.subject.meshFemale-
dc.subject.meshFibrinolytic Agents-
dc.subject.meshGuideline Adherence-
dc.subject.meshHeparin, Low-Molecular-Weight-
dc.subject.meshHumans-
dc.subject.meshProspective Studies-
dc.subject.meshVenous Thrombosis-
dc.titleThromboprophylaxis for women undergoing caesarean section.en_GB
dc.typeArticleen
dc.contributor.departmentUCD Centre for Human Reproduction, Coombe Women and Infant's University Hospital, Cork St, Dublin 8.en_GB
dc.identifier.journalIrish medical journalen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.